Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection
- 1 September 1998
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 12 (13) , 1591-1600
- https://doi.org/10.1097/00002030-199813000-00005
Abstract
To assess the dynamics of neutralizing antibodies (NAb) in long-term AIDS-free HIV-1-infected subjects and establish correlations with known markers of disease progression. Cross-sectional study using sera collected from long-term non-progressors (LTNP) 8 years after seroconversion or study entry. Longitudinal study using sera collected from LTNP at 0, 0.5, 1, 2, 4, 6, 8 and 10 years after seroconversion and, as controls, from rapid progressors. Individuals with documented AIDS-free HIV-1 infection for at least 8 years were evaluated for NAb against five heterologous HIV-1 primary isolates. In the cross-sectional study, serum viral RNA levels, CD4+ T-cell numbers and T-cell function were determined on samples collected during the eighth year of follow-up. For the longitudinal study, NAb were assessed in sequential sera taken from LTNP and rapid progressors. Serum neutralization titres found in individual sera differed from one HIV-1 isolate to another, were detected in 49–76% of LTNP, without correlation with the coreceptor usage of the isolate, and were positively associated with CD4+ T-lymphocyte counts (P = 0.0041) and T-cell function (P = 0.04). No correlation was found between NAb and the level of viral RNA in serum or the rate of CD4+ T-cell decline. Longitudinal analysis of sera from LTNP and rapid progressors showed that although several subjects in both groups had neutralizing activity at seroconversion, it thereafter became lower or no longer detectable. NAb were again found 1–4 years later and stably persisted in LTNP, but remained undetectable or at low levels in rapid progressors. NAb were preferentially found in subjects with relatively preserved T-cell function and CD4+ T-cell numbers. In these individuals, neutralizing activity against heterologous isolates increased with time. These data suggest that the capacity to produce broadly NAb is a function of the integrity of the immune system.Keywords
This publication has 37 references indexed in Scilit:
- Augmented Serum Neutralizing Activity against Primary Human Immunodeficiency Virus Type 1 (HIV‐1) Isolates in Two Groups of HIV‐1‐Infected Long‐Term NonprogressorsThe Journal of Infectious Diseases, 1997
- Correlation between susceptibility of primary HIV-1 isolates to autologous and heterologous neutralizing antibodiesAIDS, 1997
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionCell, 1996
- Kinetics of Appearance of Neutralizing Antibodies in 12 Patients with Primary or Recent HIV-1 Infection and Relationship with Plasma and Cellular Viral LoadsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Quantitative Measures of Human Immunodeficiency Virus-Specific Antibodies Predict Progression to AIDSThe Journal of Infectious Diseases, 1995
- Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.The Journal of Experimental Medicine, 1995
- Update on Long-Term Symptomless HIV Type 1 Infection in Recipients of Blood Products from a Single DonorAIDS Research and Human Retroviruses, 1995
- Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous seraAIDS, 1990